KMT5A and breast cancer: For example, Yu et al. proved that miR-7 targets H4K20 specific monomethyltransferase SET domain-containing protein 8 (SET8) and inhibits H4K20 monomethylation by down-regulating SET8 to suppress BC cell invasion [65].